• Molecular NameMarimastat
  • Synonymmarimastat
  • Weight331.413
  • Drugbank_IDDB00786
  • ACS_NO154039-60-8
  • Show 3D model
  • LogP (experiment)0.607
  • LogP (predicted, AB/LogP v2.0)0.12
  • pkaN/A
  • LogD (pH=7, predicted)0.11
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.81
  • LogSw (predicted, AB/LogsW2.0)94.96
  • Sw (mg/ml) (predicted, ACD/Labs)5.07
  • No.of HBond Donors5
  • No.of HBond Acceptors8
  • No.of Rotatable Bonds8
  • TPSA127.76
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA proposed matrix metalloproteinase inhibitor developed by British Biotech.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding95.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life8 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A